Tris Pharma, Inc.

About Tris Pharma, Inc.

Tris Pharma is dedicated to solving some of the most challenging therapeutic issues in ADHD, pain, addiction, and other central nervous system (CNS) disorders. Their mission is to make a profound impact on patients' lives worldwide by developing high-quality, patient-friendly therapeutics using innovative, proprietary technologies.

Products & Services

ADHD Therapies:A portfolio of four leading therapies designed to enhance patient care and experience for both adults and children with ADHD.

Pain Therapies:Investigational therapies including Cebranopadol, a first-in-class dual-NMR agonist for moderate-to-severe pain.

Addiction and Other CNS Disorders:Development of therapies targeting addiction and other CNS disorders to address unmet patient needs.

LiquiXR Technology:Proprietary technology powering the development of over a dozen medicines and programs.

Specialties

ADHD Therapies Pain Management Addiction Treatment Central Nervous System Disorders Proprietary Drug Delivery Technologies (LiquiXR)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 16600000 MR: - FA: up to $16.6 million FAN: 16600000	D: 2023-08-28 FD: 2023-08-28	1 investors

Grant Latest

2023-08-28

$16.6M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Amir Kalali

Professor of Psychiatry and Chairperson

G

Geraldine Dawson

William Cleland Distinguished Professor of Psychiatry and Behavioral Sciences at Duke University

S

Stephen Faraone

Distinguished Professor

R

Robert L. Findling

Professor and Chair, Department of Psychiatry, VCU School of Medicine

R

Roger S. McIntyre

Professor of Psychiatry and Pharmacology

A

Alan F. Schatzberg

Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences and Chair of the Department at Stanford University

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

Tris Pharma, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised